Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147K Hold
24,200
0.07% 193
2026
Q1
$125K Sell
24,200
-2,000
-8% -$12.5K 0.07% 173
2025
Q4
$192K Sell
26,200
-178
-0.7% -$1.72K 0.1% 174
2025
Q3
$263K Sell
26,378
-1,523
-5% -$16.9K 0.15% 158
2025
Q2
$252K Hold
27,901
0.18% 152
2025
Q1
$179K Buy
27,901
+386
+1% +$3.44K 0.15% 149
2024
Q4
$262K Buy
27,515
+633
+2% +$5.56K 0.19% 142
2024
Q3
$220K Hold
26,882
0.16% 143
2024
Q2
$364K Sell
26,882
-17,781
-40% -$149K 0.28% 112
2024
Q1
$313K Hold
44,663
0.18% 135
2023
Q4
$489K Buy
44,663
+2,286
+5% +$22.4K 0.34% 95
2023
Q3
$465K Buy
42,377
+24,428
+136% +$349K 0.35% 91
2023
Q2
$283K Buy
17,949
+867
+5% +$10.1K 0.23% 101
2023
Q1
$223K Buy
+17,082
New +$140K 0.21% 99

Other funds holding ENVX

WESPAC Advisors's ENVX Position: Q2 2026 in Review

WESPAC Advisors held its Enovix (ENVX) position steady in Q2 2026 at 24,200 shares worth $147K. The position accounts for 0.07% of the portfolio, ranked #193.

WESPAC Advisors first reported a position in ENVX in Q1 2023 and has held it in 14 quarters since. The position peaked at $489K in Q4 2023. 145 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • WESPAC Advisors held 24,200 shares of Enovix worth $147K as of Q2 2026.
  • WESPAC Advisors left its Enovix share count unchanged in Q2 2026.
  • Enovix made up 0.07% of WESPAC Advisors's portfolio in Q2 2026, its #193 holding.
  • WESPAC Advisors first reported a position in Enovix in Q1 2023 and has held it in 14 quarters since.
  • WESPAC Advisors's Enovix position peaked at $489K in Q4 2023.
  • 145 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on WESPAC Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.